Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NERV Minerva Neurosciences

盘后交易 03-18 16:46:29 EDT

7.78

-0.07

-0.89%

盘后7.78

+0.000.00%

16:10 EDT

最高8.11	最低7.63	成交量51.30万
今开7.92	昨收7.85	日振幅6.11%
总市值3.37亿	流通市值4,230万	总股本4,327万
成交额401.96万	换手率9.44%	流通股本543.70万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NERV","market":"US","secType":"STK","nameCN":"Minerva Neurosciences","latestPrice":7.78,"timestamp":1773864000000,"preClose":7.85,"halted":0,"volume":512984,"hourTrading":{"tag":"盘后","latestPrice":7.78,"preClose":7.78,"latestTime":"16:10 EDT","volume":7341,"amount":57112.98,"timestamp":1773864605016,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.008917197452229223,"floatShares":5437017,"shares":43274398,"eps":-34.67,"marketStatus":"盘后交易","change":-0.07,"latestTime":"03-18 16:46:29 EDT","open":7.92,"high":8.11,"low":7.63,"amount":4019646.183008,"amplitude":0.061146,"askPrice":8.79,"askSize":100,"bidPrice":7.65,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-34.67,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1773878400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1404187200000,"exchange":"NASDAQ","adjPreClose":7.85,"preHourTrading":{"tag":"盘前","latestPrice":7.95,"preClose":7.85,"latestTime":"09:28 EDT","volume":1801,"amount":14367.8004193,"timestamp":1773840530751,"change":0.1,"changeRate":0.012739,"amplitude":0.011465},"postHourTrading":{"tag":"盘后","latestPrice":7.78,"preClose":7.78,"latestTime":"16:10 EDT","volume":7341,"amount":57112.98,"timestamp":1773864605016,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.784202,"impliedVol":4.114,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/NERV","defaultTab":"news","newsList":[{"id":"1102941713","title":"Minerva Neurosciences 计划通过多次发行募集高达2亿美元证券","url":"https://stock-news.laohu8.com/highlight/detail?id=1102941713","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102941713?lang=zh_cn&edition=full","pubTime":"2026-03-11 21:23","pubTimestamp":1773235420,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）的一份最新文件披露，生物制药公司 Minerva Neurosciences Inc. 可能通过多次证券发行，筹集最高达2亿美元的资金。这一举措旨在为公司的运营和研发活动提供资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2614851150","title":"Minerva Neurosciences, Inc盘中异动 股价大跌6.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614851150","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614851150?lang=zh_cn&edition=full","pubTime":"2026-02-25 03:26","pubTimestamp":1771961173,"startTime":"0","endTime":"0","summary":"北京时间2026年02月25日03时26分，Minerva Neurosciences, Inc股票出现波动，股价急速跳水6.57%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Moolec Science Sa C/Wts 30/01/2028、Edesa Biotech, Inc.、Palvella Therapeutics, Inc.涨幅较大，Edesa Biotech, Inc.、Biorestorative Therapies, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为976.61%、851.28%、603.23%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Edesa Biotech, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为599.00%、96.77%、54.12%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022503261397a6e4d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022503261397a6e4d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2610626535","title":"Minerva Neurosciences, Inc盘中异动 早盘大幅上涨6.25%报5.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610626535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610626535?lang=zh_cn&edition=full","pubTime":"2026-02-09 23:14","pubTimestamp":1770650071,"startTime":"0","endTime":"0","summary":"北京时间2026年02月09日23时14分，Minerva Neurosciences, Inc股票出现波动，股价大幅拉升6.25%。截至发稿，该股报5.10美元/股，成交量1.8585万股，换手率0.04%，振幅8.12%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Liminatus Pharma, Inc.、Lunai Bioworks Inc.、Humacyte, Inc.涨幅较大，Agomab Therapeutics Nv、Liminatus Pharma, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为141.48%、48.34%、23.35%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Moolec Science Sa C/Wts 30/01/2028、Genenta Science Spa，振幅分别为34.95%、33.80%、28.39%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209231431a6e6aad6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209231431a6e6aad6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":1},{"id":"2601079548","title":"Minerva Neurosciences, Inc盘中异动 早盘快速拉升5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601079548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601079548?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:53","pubTimestamp":1767797627,"startTime":"0","endTime":"0","summary":"北京时间2026年01月07日22时53分，Minerva Neurosciences, Inc股票出现波动，股价快速拉升5.69%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为2.01%。其相关个股中，Monte Rosa Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Ventyx Biosciences, Inc.涨幅较大，Cardio Diagnostics Holdings Inc.、Aspire Biopharma Holdings, Inc.、居里较为活跃，换手率分别为993.41%、242.88%、92.83%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Aspire Biopharma Holdings, Inc.、Salarius Pharmaceuticals, Inc.，振幅分别为50.85%、32.48%、30.40%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010722534797a133a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010722534797a133a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2594152542","title":"Minerva Neurosciences, Inc盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594152542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594152542?lang=zh_cn&edition=full","pubTime":"2025-12-27 04:09","pubTimestamp":1766779768,"startTime":"0","endTime":"0","summary":"北京时间2025年12月27日04时09分，Minerva Neurosciences, Inc股票出现异动，股价急速拉升5.04%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Can Fite Biopharma Ltd、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为996.62%、398.21%、161.74%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Briacell Therapeutics Corp C/Wts 26/02/2026、Cdt Equity Inc C/Wts 22/09/2028，振幅分别为97.83%、75.59%、54.26%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122704092897a0bf2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122704092897a0bf2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"1194783703","title":"Minerva Neurosciences：研发及管理成本可能上升，但我们有良好条件为Roluperidone在美国的第三阶段、NDA重新提交与上市准备提供资金","url":"https://stock-news.laohu8.com/highlight/detail?id=1194783703","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194783703?lang=zh_cn&edition=full","pubTime":"2025-11-05 20:36","pubTimestamp":1762346184,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences：研发及管理成本可能上升，但我们有良好条件为Roluperidone在美国的第三阶段、NDA重新提交与上市准备提供资金","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"1144077866","title":"Minerva Neurosciences：推动Roluperidone治疗精神分裂症负面症状的前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1144077866","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144077866?lang=zh_cn&edition=full","pubTime":"2025-11-05 20:32","pubTimestamp":1762345934,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences：推动Roluperidone治疗精神分裂症负面症状的前景","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2577322533","title":"Minerva Neurosciences, Inc盘中异动 大幅下挫5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577322533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577322533?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:30","pubTimestamp":1761226224,"startTime":"0","endTime":"0","summary":"北京时间2025年10月23日21时30分，Minerva Neurosciences, Inc股票出现波动，股价急速下跌5.20%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Ventyx Biosciences, Inc.、Ethzilla Corporation C/Wts 06/11/2025、Ibio, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Ventyx Biosciences, Inc.、Ibio, Inc.较为活跃，换手率分别为145.33%、70.98%、57.46%，振幅较大的相关个股有Ventyx Biosciences, Inc.、Entero Therapeutics Inc.、Tango Therapeutics, Inc.，振幅分别为8.03%、7.08%、6.87%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102321302594d9d1a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102321302594d9d1a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":1},{"id":"1138956005","title":"Minerva Neurosciences股价在公司获得高达2亿美元的私人配售后大幅上涨，涨幅达163.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138956005","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138956005?lang=zh_cn&edition=full","pubTime":"2025-10-21 21:38","pubTimestamp":1761053890,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences的股价在公司获得高达2亿美元的私人配售后涨幅超过两倍，最新涨幅为163.2%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"1129991095","title":"Minerva Neurosciences- 进一步可能获得4000万美元收益，与按现金行使B系列认股权证有关，取决于达成里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1129991095","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129991095?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:03","pubTimestamp":1761048191,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences- 进一步可能获得4000万美元收益，与按现金行使B系列认股权证有关，取决于达成里程碑","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"1159095091","title":"Minerva Neurosciences将扩大董事会规模并任命最多三位董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1159095091","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159095091?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:03","pubTimestamp":1761048189,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences将扩大董事会规模并任命最多三位董事","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"1140588980","title":"Minerva Neurosciences - 预计将获得足够资金以支持Roluperidone的确认性3期试验及向FDA重新提交NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=1140588980","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140588980?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:03","pubTimestamp":1761048187,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences - 预计将获得足够资金以支持Roluperidone的确认性3期试验及向FDA重新提交NDA","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"1186159233","title":"Minerva Neurosciences宣布融资最高达2亿美元以推进Roluperidone治疗精神分裂症患者的负面症状，进行三期确认试验，并重新提交新药申请，准备美国商业上市（如获批准）","url":"https://stock-news.laohu8.com/highlight/detail?id=1186159233","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186159233?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:01","pubTimestamp":1761048071,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences宣布融资最高达2亿美元，以推进Roluperidone治疗精神分裂症患者负面症状的三期确认试验，并重新提交新药申请，准备在美国上市（如获批准）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2574176172","title":"Minerva Neurosciences, Inc盘中异动 早盘大幅下挫7.77%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574176172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574176172?lang=zh_cn&edition=full","pubTime":"2025-10-09 21:32","pubTimestamp":1760016720,"startTime":"0","endTime":"0","summary":"北京时间2025年10月09日21时32分，Minerva Neurosciences, Inc股票出现波动，股价急速下挫7.77%。截至发稿，该股报2.61美元/股，成交量6.7083万股，换手率0.96%，振幅1.41%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Turn Therapeutics Inc.、Galecto, Inc.、Biodexa Pharmaceuticals Plc涨幅较大，Cdt Equity Inc.、Alaunos Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1618.06%、930.18%、635.88%，振幅较大的相关个股有Turn Therapeutics Inc.、Galecto, Inc.、Novabay Pharmaceuticals, Inc.，振幅分别为42.86%、22.06%、12.08%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009213200a458601c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009213200a458601c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2518003352","title":"Minerva Neurosciences, Inc盘中异动 大幅跳水6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518003352","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518003352?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:15","pubTimestamp":1741634146,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时15分，Minerva Neurosciences, Inc股票出现波动，股价急速下跌6.10%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6302.04%、3861.36%、1023.87%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031546a26aa67f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031546a26aa67f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2517369928","title":"Minerva Neurosciences, Inc盘中异动 快速上涨5.06%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517369928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517369928?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:17","pubTimestamp":1741198670,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时17分，Minerva Neurosciences, Inc股票出现异动，股价急速拉升5.06%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为1.39%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为948.37%、305.84%、301.30%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.，振幅分别为82.59%、54.27%、47.22%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306021750989d778e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306021750989d778e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2516753670","title":"Minerva Neurosciences, Inc盘中异动 急速下挫7.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516753670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516753670?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:53","pubTimestamp":1741099982,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时53分，Minerva Neurosciences, Inc股票出现异动，股价大幅跳水7.19%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1138.13%、1114.47%、515.66%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Celularity Inc C/Wts 16/07/2026 、Nutriband Inc C/Wts ，振幅分别为44.32%、37.67%、25.66%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225302abe7f68c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225302abe7f68c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2516552277","title":"Minerva Neurosciences, Inc2024财年实现净利润1.44百万美元，同比增加104.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516552277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516552277?lang=zh_cn&edition=full","pubTime":"2025-03-02 00:00","pubTimestamp":1740844851,"startTime":"0","endTime":"0","summary":"3月2日，Minerva Neurosciences, Inc公布财报，公告显示公司2024财年净利润为1.44百万美元，同比增加104.80%；其中营业收入为0.00美元，每股基本收益为0.19美元。从资产负债表来看，Minerva Neurosciences, Inc总负债62.84百万美元，其中短期债务0.00美元，资产负债比为0.60，流动比率为7.85。机构评级：截至2025年3月2日，当前有1家机构对Minerva Neurosciences, Inc目标价做出预测，其中目标均价为5.00美元，其中最低目标价为5.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000104a259dc8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000104a259dc8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV"],"gpt_icon":0},{"id":"1193483570","title":"Minerva Neurosciences 2024年第四季度GAAP每股收益$(0.56)优于预期的$(1.05)，截至2024年12月31日现金、现金等价物和受限制现金约为$21.5M","url":"https://stock-news.laohu8.com/highlight/detail?id=1193483570","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193483570?lang=zh_cn&edition=full","pubTime":"2025-02-25 20:50","pubTimestamp":1740487840,"startTime":"0","endTime":"0","summary":"Minerva Neurosciences 报告季度亏损每股$，优于分析师一致预期的每股亏损$，超出达46.67%。相比去年同期每股亏损$，这是增长了52.94%。以上内容来自Benzinga Earnings专栏，原文如下：$Minerva Neurosciences$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 46.67 percent. This is a 52.94 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Minerva Neurosciences 2024年第四季度GAAP每股收益$(0.56)优于预期的$(1.05)，截至2024年12月31日现金、现金等价物和受限制现金约为$21.5M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NERV"],"gpt_icon":0},{"id":"2513720695","title":"Minerva Neurosciences, Inc盘中异动 股价大涨8.18%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720695?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:05","pubTimestamp":1740409533,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时05分，Minerva Neurosciences, Inc股票出现波动，股价大幅上涨8.18%。截至发稿，该股报1.97美元/股，成交量570股，换手率0.01%，振幅1.65%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Pepgen Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为162.64%、71.17%、25.66%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、42.86%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230533a2521cea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230533a2521cea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.minervaneurosciences.com","stockEarnings":[{"period":"1week","weight":-0.0113},{"period":"1month","weight":0.252},{"period":"3month","weight":1.0658},{"period":"6month","weight":2.8107},{"period":"1year","weight":4.0321},{"period":"ytd","weight":0.9527}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0161},{"period":"3month","weight":-0.0009},{"period":"6month","weight":0.0129},{"period":"1year","weight":0.1827},{"period":"ytd","weight":-0.0163}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Minerva Neurosciences, Inc.于2007年4月23日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于开发和商业化中枢神经系统疾病的专利候选产品。其主要候选药物罗鲁哌酮正在开发中，用于治疗精神分裂症的阴性症状，计划进行3期确认性试验。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.082044},{"month":2,"riseRate":0.25,"avgChangeRate":-0.062323},{"month":3,"riseRate":0.416667,"avgChangeRate":0.016645},{"month":4,"riseRate":0.454545,"avgChangeRate":0.050114},{"month":5,"riseRate":0.545455,"avgChangeRate":0.1467},{"month":6,"riseRate":0.636364,"avgChangeRate":0.069702},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.035509},{"month":8,"riseRate":0.5,"avgChangeRate":0.304921},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.003875},{"month":10,"riseRate":0.25,"avgChangeRate":-0.122814},{"month":11,"riseRate":0.5,"avgChangeRate":0.078313},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.079275}],"exchange":"NASDAQ","name":"Minerva Neurosciences","nameEN":"Minerva Neurosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Minerva Neurosciences(NERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Minerva Neurosciences,NERV,Minerva Neurosciences股票,Minerva Neurosciences股票老虎,Minerva Neurosciences股票老虎国际,Minerva Neurosciences行情,Minerva Neurosciences股票行情,Minerva Neurosciences股价,Minerva Neurosciences股市,Minerva Neurosciences股票价格,Minerva Neurosciences股票交易,Minerva Neurosciences股票购买,Minerva Neurosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Minerva Neurosciences(NERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}